Refresh
Company Event • 04 Nov 2021 13:00 • Latest
2Q Financial Results Briefing for the Fiscal Year Ended March 2022 Q&A
Location:Japan
2Q Financial Results Briefing for the Fiscal Year Ended March 2022 Q&A
Speakers
- Shin Ashida (Representative Director Chairman, President and CEO, JCR Pharmaceuticals Co., Ltd.)
- Toru Ashida (Senior Vice President Sales and Administration Executive Director, Sales Division, JCR Pharmaceuticals Co., Ltd.)
- Hiroyuki Sonoda Ph.D. (Vice President Research and Corporate Strategy Executive Director, Research Division, JCR Pharmaceuticals Co., Ltd.)
- Yutaka Honda (Corporate Officer Executive Director, Administration Division (reporting to the president), JCR Pharmaceuticals Co., Ltd.)
- Kazunori Tanizawa (Corporate Officer Executive Director, Development Division, JCR Pharmaceuticals Co., Ltd.)
- Yoshihiro Ohta (Director Accounting Dept. Management Division, JCR Pharmaceuticals Co., Ltd.)
Analysts
- Hidemaru Yamaguchi (Analyst, Citigroup Global Markets Japan Inc.)
- Kazuaki Hashiguchi (Analyst, Daiwa Securities Co. Ltd.)
- Shohei Oda (Analyst, Morgan Stanley MUFG Securities Co., Ltd.)
- Fumiyoshi Sakai (Analyst, Credit Suisse Securities (Japan) Limited)
- Shinya Tsuzuki (Analyst, Mizuho Securities Co., Ltd.)
- Stephen Barker (Analyst, Jefferies Japan Limited)
- Naomi Kumagai (Analyst, Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.)
- Ryuta Kawamura (Analyst, SBI SECURITIES Co.,Ltd.)
- Hiroyuki Matsubara (Analyst, Nomura Securities Co., Ltd.)
- Takashi Akahane (Analyst, Tokai Tokyo Research Institute Co., Ltd.)
- Mizuno (Analyst, Tokio Marine Asset Management Co., Ltd)
- Sato (Analyst, Schroders Investment Management (Japan) Limited)
- Shinichiro Muraoka (Analyst, Morgan Stanley MUFG Securities Co., Ltd.)
Duration
- Presentation: 64 minutes
- Q&A: 64 minutes
Company Event • 02 Nov 2021 14:00
2Q Financial Results Briefing for the Fiscal Year Ended March 2022 Presentation
Location:Japan
2Q Financial Results Briefing for the Fiscal Year Ended March 2022 Presentation
Speakers
- Shin Ashida (Representative Director Chairman, President and CEO, JCR Pharmaceuticals Co., Ltd.)
- Kazunori Tanizawa (Corporate Officer Executive Director, Development Division, JCR Pharmaceuticals Co., Ltd.)
- Yoshihiro Ohta (Director Accounting Dept. Management Division, JCR Pharmaceuticals Co., Ltd.)
Company Event • 18 May 2021 12:00
Financial Results Briefing for the Fiscal Year Ended March 2021 Q&A
Location:Japan
Financial Results Briefing for the Fiscal Year Ended March 2021 Q&A
Speakers
- Shin Ashida (Representative Director Chairman, President and CEO, JCR Pharmaceuticals Co., Ltd.)
- Toru Ashida (Vice President In charge of Corporate Strategy and Head of Sales DIvision Executive Director, Sales Division, JCR Pharmaceuticals Co., Ltd.)
- Hiroyuki Sonoda Ph.D. (Senior Executive Director Head of Research and Development Division Executive Director, Research Division and Director, Drug Discovery Research Division, JCR Pharmaceuticals Co., Ltd.)
- Yutaka Honda (Senior Corporate Officer Head of Corporate Planning Division Director, Office of the President and Executive Director, Corporate Planning Division, JCR Pharmaceuticals Co., Ltd.)
- Kazunori Tanizawa (Corporate Officer Executive Director, Development Division, JCR Pharmaceuticals Co., Ltd.)
- Yoshihiro Ohta (Director Accounting Dept. Management Division, JCR Pharmaceuticals Co., Ltd.)
Analysts
- Hidemaru Yamaguchi (Analyst, Citigroup Global Markets Japan Inc.)
- Kazuaki Hashiguchi (Analyst, Daiwa Securities Co. Ltd.)
- Shohei Oda (Analyst, Morgan Stanley MUFG Securities Co., Ltd.)
- Fumiyoshi Sakai (Analyst, Credit Suisse Securities (Japan) Limited)
- Shinya Tsuzuki (Analyst, Mizuho Securities Co., Ltd.)
- Tatsuyuki Arai (Analyst, BofA Securities Japan Co., Ltd.)
- Ryuta Kawamura (Analyst, SBI SECURITIES Co.,Ltd.)
- Hiroyuki Matsubara (Analyst, Nomura Securities Co., Ltd.)
- Muraoka (Analyst, Morgan Stanley MUFG Securities Co., Ltd.)
- Mizuno (Analyst, Tokio Marine Asset Management Co., Ltd)
Duration
- Presentation: 59 minutes
- Q&A: 59 minutes
Company Event • 17 May 2021 14:00
Financial Results Briefing for the Fiscal Year Ended March 2021 Presentation
Location:Japan
Financial Results Briefing for the Fiscal Year Ended March 2021 Presentation
Speakers
- Shin Ashida (Representative Director Chairman, President and CEO, JCR Pharmaceuticals Co., Ltd.)
- Kazunori Tanizawa (Corporate Officer Executive Director, Development Division, JCR Pharmaceuticals Co., Ltd.)
- Yoshihiro Ohta (Director Accounting Dept. Management Division, JCR Pharmaceuticals Co., Ltd.)
Duration
- Presentation: 0 minutes
- Q&A: 0 minutes
No more events